Pitrakinra

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NamePitrakinra
Drug Alias NameAerovantAER-001BAY-16-9996
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 13 receptor inhibitorsInterleukin-4 receptor subunit alpha inhibitors
TargetsInterleukin-4 receptor subunit alphaInterleukin 13 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandHungary +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAerovance Inc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksWikipedia